Congratulations to Anthony Zietman, MD, Interim Chief of the Department of Radiation Oncology, who was among seven outstanding members of the Mass General Brigham community recently recognized for their excellence in medical education.
Departments, Centers, & Programs:
Genitourinary Cancer Center
55 Fruit Street
Boston, MA 02114
Clark Center for Radiation Oncology
100 Blossom Street
Boston, MA 02114-2606
- MD, London University
- MD, University of London
- MD, University of London, School of Medicine/University College
- Residency, Massachusetts General Hospital
- Residency, Middlesex Hosp/England
- Residency, Mt. Vernon Hospital
- Residency, The Middlesex Hospital
- Residency, Westminster & Netherne Hospitals
- Residency, Westminster Hospital
- Fellowship, Massachusetts General Hospital
- Fellowship, Middlesex Hospital
American Board Certifications
- Radiation Oncology, American Board of Radiology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A.L., O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA 16:302 1202-9 2009
Zietman A.L., Bae K., Slater J.D., Shipley W.U., Efstathiou J.A., Coen J.J., Bush D.A., Lunt M., Spiegel D.Y., Skowronski R., Jabola B.R., Rossi C.J. A randomized trial comparing conventional dose conformal radiation therapy with high-dose in early stage adenocarcinoma of the prostate. Long-term results from Proton Radiaiton Oncology Group (PROG)/American College of Radiology (ACR) 95-09. J. Clin. Oncol. (in press) 2009.
Zietman A.L.. The Titanic and The Iceberg: prostate proton therapy and healthcare economics. J. Clin. Oncol. 25: 3565-66, 2007.
Zietman A.L.. Evidence-based medicine, conscience-based medicine, and the management of low-risk prostate cancer.J. Clin Oncol. 27:4935-6, 2009
- Feb | 2 | 2017
"Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer," co-authored by Dr. William Shipley and Dr. Anthony Zietman, was published in NEJM.